Caplin Point Laboratories Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 15.20 | 15.19 | 15.18 | 15.16 | 15.13 |
Reserves | 1,685.73 | 1,374.96 | 1,124.73 | 915.49 | 743.54 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 1,700.93 | 1,390.15 | 1,139.91 | 930.65 | 758.67 |
Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Unsecured Loans | 1.66 | 0.93 | 1.34 | 0.62 | 1.33 |
Total Debt | 1.66 | 0.93 | 1.34 | 0.62 | 1.33 |
Other Liabilities | 3.32 | 3.13 | 1.80 | 2.68 | 3.49 |
Total Liabilities | 1,705.91 | 1,394.21 | 1,143.05 | 933.95 | 763.49 |
APPLICATION OF FUNDS : | |||||
Gross Block | 381.41 | 318.45 | 285.13 | 268.64 | 266.23 |
Less: Accumulated Depreciation | 176.15 | 152.66 | 128.28 | 106.18 | 83.55 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 205.26 | 165.79 | 156.85 | 162.46 | 182.68 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 20.64 | 27.75 | 42.68 | 2.60 | 1.36 |
Investments | 802.44 | 584.15 | 485.15 | 264.70 | 149.18 |
Current Assets, Loans & Advances | |||||
Inventories | 66.26 | 86.25 | 51.53 | 42.81 | 24.87 |
Sundry Debtors | 175.33 | 128.67 | 88.24 | 53.73 | 98.46 |
Cash and Bank Balance | 214.71 | 215.78 | 271.38 | 316.08 | 345.49 |
Loans and Advances | 58.06 | 34.42 | 40.37 | 141.08 | 33.28 |
Total Current Assets | 514.36 | 465.12 | 451.52 | 553.70 | 502.10 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 88.64 | 114.11 | 135.03 | 97.22 | 75.37 |
Provisions | 10.68 | 3.99 | 10.96 | 1.20 | 1.16 |
Total CL & Provisions | 99.32 | 118.10 | 145.99 | 98.42 | 76.53 |
Net Current Assets | 415.04 | 347.02 | 305.53 | 455.28 | 425.57 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liability | 9.25 | 10.00 | 14.14 | 21.79 | 20.97 |
Net Deferred Tax | -9.25 | -10.00 | -14.14 | -21.79 | -20.97 |
Other Assets | 271.78 | 279.50 | 166.98 | 70.70 | 25.67 |
Total Assets | 1,705.91 | 1,394.21 | 1,143.05 | 933.95 | 763.49 |
Contingent Liabilities | 0.64 | 0.64 | 0.64 | 0.71 | 1.02 |